Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

OFT raises the stakes in Lloyds takeover battle

Article Abstract:

The UK Office of Fair Trading (OFT) is to refer retail prices for non-prescription drugs to the restrictive practices court. This could mean price competition among retailers, though no action is likely to be taken until 1998. The acquisition of Lloyds Chemists by Unichem would create a company with critical mass in addition to reducing costs through economies of scale in buying drugs. Gehe may also make a bid for Lloyds, which could lead Unichem to increase its offer.

Author: Ahmad, Sameena
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Proprietary Preparations, Laws, regulations and rules, Pharmaceutical industry, Proprietary drugs

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Llods: Unichem's remedy

Article Abstract:

Unichem is acquiring Lloyds Chemist through an agreed bid for 514 million pounds sterling. If the deal goes through, Unichem aims to use its own Moss brand to replace the Lloyds Chemists brand. The deal would boost both Unichem's retail and its wholesale operations. Another company may make a rival offer, and there has been speculation that Gehe, a chemicals supplier from Germany, could do this. Unichem could increase its offer if a rival bid emerges.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Drug Store Chains, Chain stores

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


UniChem in spotlight

Article Abstract:

UniChem is seeking to acquire Lloyds Chemists and is competing with Gehe for this acquisition. UniChem saw a rise in its share price on Feb 21 1996, and this is being examined by the UK Takeover Panel to ensure that share price manipulation has not occurred. UniChem acquired a stake of almost 10% in Lloyds as a result of the rise in UniChem's share price. Purchases by institutional investors could have led to the share price rise for UniChem.

Author: Larsen, Peter Thal
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Mergers, acquisitions and divestments, Drugstores, UniChem PLC, Lloyds Chemists PLC
Similar abstracts:
  • Abstracts: Fiscal adjustment in EU countries: a balance sheet approach. The determination of capital controls: which role do exchange rate regimes play?
  • Abstracts: A corporate trend in need of reversal. Personal health insurance. Stress in uncertain times
  • Abstracts: Get-out clause. Supermarket battle spills over into banking. Telebanking: direct route to Scotland
  • Abstracts: Japan: breaking the barrier. Japan: battling on
  • Abstracts: A stake in the gambling world. Man for all seasons. Nasty attack: better now
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.